Filing metadata

Accession number
0001209191-22-054075
Form type
Form 4
Filer
Aclaris Therapeutics, Inc.
CIK
CIK 1557746
Filed
Oct 19, 2022
Reporting period
Oct 17, 2022
Description
Insider transaction

Explore SEC Filings Hub